Hub : Traits :

Primary Biliary Cirrhosis

152 significantly associated models · 41 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 67074053 68559650 1 1 3.3e-21 7.5e-28 2.0e-08 74 IL12RB2
2 1 196798989 198436809 1 1 1.9e-09 1.0e-11 1.1e-03 77 DENND1B
3 2 190521054 191931464 1 1 4.1e-10 2.3e-14 1.2e-05 67 INPP1
4 3 118779507 119458851 2 2 4.2e-09 4.3e-15 1.3e-05 69 ARHGAP31 KTELC1
5 3 159013779 160970437 5 7 1.7e-22 1.4e-23 NaN NaN IL12A KPNA4 SMC4 TRIM59
6 4 258627 1694809 3 1 1.2e-07 2.7e-07 7.0e-02 88 SLC26A1
7 4 102852939 104627833 4 1 8.2e-10 8.2e-10 1.0e+00 100 SLC9B1
8 5 35608310 36124514 1 1 4.5e-09 4.7e-11 1.7e-03 77 IL7R
9 7 127878155 129284182 2 2 2.2e-23 5.1e-23 4.2e-04 87 IRF5
10 11 63316786 64820283 2 1 2.8e-09 1.7e-09 1.5e-01 94 CCDC88B
11 11 118365263 119765318 2 1 2.0e-10 1.1e-13 1.1e-04 73 DDX6
12 12 111154626 112582540 1 1 1.4e-07 3.2e-08 3.5e-03 72 SH2B3
13 15 78520204 79933757 1 1 2.4e-07 1.6e-07 1.0e+00 100 CTSH
14 16 10329905 12138068 4 2 6.6e-14 2.4e-14 1.0e+00 100 DEXI RMI2
15 17 37101380 39048774 8 1 3.2e-11 2.6e-11 1.0e-01 94 GSDMB
16 19 10283932 11730690 1 1 2.0e-07 1.0e-10 5.0e-10 7 CARM1
17 22 39064209 40479448 1 1 6.7e-12 2.2e-11 4.4e-01 99 SYNGR1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Depressed Affect (Nagel 2018) 1.09 1 0 0.0 0.00 1.00000 SH2B3
Neuroticism (Nagel 2018) 0.95 1 0 0.0 0.00 1.00000 DENND1B
Worry (Nagel 2018) 1.08 1 0 0.0 0.00 1.00000 DENND1B
Alzheimer’s Disease (in mother) 1.73 2 0 0.0 0.00 1.00000 CTSH SLC26A1
Alzheimer’s Disease (including proxy) 1.62 1 0 0.0 0.00 1.00000 SLC26A1
Crohns Disease (2017) 3.84 6 3 6.7 0.65 0.15829 CCDC88B DENND1B GSDMB IL12RB2 RMI2 SYNGR1
Irritable Bowel Disease (IBD) 4.57 7 4 8.9 0.65 0.11556 CCDC88B DENND1B GSDMB IL12RB2 IRF5 RMI2 SYNGR1
Ulcerative Colitis (UC) 3.88 5 1 2.2 0.60 0.20360 GSDMB IL12RB2 IRF5 SLC9B1 SYNGR1
Reaction Time 2.00 2 1 2.2 0.00 1.00000 CARM1 SH2B3
Prostate Cancer 2.37 1 0 0.0 0.00 1.00000 TRIM59
Coronary Artery Disease (CAD) 1.63 1 0 0.0 0.00 1.00000 SH2B3
Crohns Disease (2012) 2.98 4 0 0.0 0.38 0.61698 CCDC88B GSDMB IL12RB2 RMI2
Fasting Glucose 2.58 1 0 0.0 0.00 1.00000 SLC9B1
HDL Cholesterol 2.02 2 1 2.2 0.00 1.00000 GSDMB SYNGR1
LDL Cholesterol 4.53 3 1 2.2 0.00 1.00000 CARM1 SH2B3 TRIM59
Lupus 10.85 5 1 2.2 0.92 0.00976 DEXI GSDMB IL12A IL12RB2 IRF5
Rheumatoid Arthritis 5.13 4 1 2.2 0.99 0.00725 DDX6 GSDMB SH2B3 SYNGR1
Ulcerative Colitis 3.14 3 1 2.2 0.00 1.00000 GSDMB IL12RB2 IRF5
Blood Eosinophil Count 12.05 10 6 13.3 0.28 0.39726 CARM1 CCDC88B DDX6 DENND1B DEXI GSDMB IL7R IRF5 SH2B3 SLC9B1
Blood Platelet Count 2.13 9 5 11.1 0.25 0.52456 GSDMB INPP1 IRF5 KPNA4 RMI2 SH2B3 SMC4 SYNGR1 TRIM59
Blood Red Count 1.64 4 1 2.2 0.08 0.88213 KPNA4 SH2B3 SLC9B1 TRIM59
Blood White Count 8.95 7 2 4.4 0.13 0.78375 CARM1 DDX6 DEXI GSDMB IL7R SH2B3 SLC9B1
Heel T-Score 1.22 8 1 2.2 -0.46 0.21698 CCDC88B DDX6 IL12A IL12RB2 IRF5 KPNA4 SMC4 TRIM59
BMI 0.56 1 0 0.0 0.00 1.00000 DENND1B
Height 0.37 5 2 4.4 -0.22 0.71605 CARM1 IL7R INPP1 SH2B3 SYNGR1
Waist Hip Ratio (WHR) 0.96 1 1 2.2 0.00 1.00000 SLC26A1
Systolic Blood Pressure 3.74 4 4 8.9 0.98 0.00036 KPNA4 SH2B3 SMC4 TRIM59
Smoking Status 1.03 1 0 0.0 0.00 1.00000 CCDC88B
Allergy or Eczema 7.32 6 4 8.9 0.18 0.73297 DDX6 DEXI GSDMB IL7R SH2B3 SLC9B1
Cardiovascular Disease 3.62 7 2 4.4 0.81 0.01577 CARM1 CCDC88B KPNA4 SH2B3 SLC26A1 SMC4 TRIM59
Hypothyroidism (self reported) 8.47 7 3 6.7 0.67 0.07106 CCDC88B IL12A IL12RB2 IL7R IRF5 SH2B3 SYNGR1
Respiratory disease 7.17 3 3 6.7 0.00 1.00000 DEXI GSDMB IL7R
Type 2 Diabetes (T2D) (2018) 1.72 2 0 0.0 0.00 1.00000 SH2B3 TRIM59
Lung FEV1/FVC ratio 0.75 2 1 2.2 0.00 1.00000 GSDMB IL7R
Lung FVC 0.83 3 0 0.0 0.00 1.00000 DEXI GSDMB SH2B3
Neuroticism 1.00 1 0 0.0 0.00 1.00000 DENND1B
Chronotype (morning person) 1.61 2 0 0.0 0.00 1.00000 IL12RB2 KPNA4
Hair Pigment 0.22 3 2 4.4 0.00 1.00000 CARM1 SH2B3 SYNGR1
Tanning 0.37 2 1 2.2 0.00 1.00000 SH2B3 SYNGR1
Number of treatments/medications taken 3.28 2 1 2.2 0.00 1.00000 SH2B3 TRIM59
Sensitivity / hurt feelings 0.99 1 0 0.0 0.00 1.00000 DENND1B
Other serious medical condition/disability diagnosed by doctor 1.71 1 0 0.0 0.00 1.00000 DEXI
Ever used hormone-replacement therapy (HRT) 2.49 1 0 0.0 0.00 1.00000 TRIM59
Systolic blood pressure, automated reading 3.01 5 2 4.4 0.87 0.02579 KPNA4 SH2B3 SLC26A1 SMC4 TRIM59
Impedance of leg (right) 0.95 3 0 0.0 0.00 1.00000 DENND1B KPNA4 TRIM59
Leg fat-free mass (left) 0.78 1 0 0.0 0.00 1.00000 SH2B3
Trunk fat percentage 0.74 1 1 2.2 0.00 1.00000 SLC26A1
Hand grip strength (right) 0.76 1 0 0.0 0.00 1.00000 IRF5
Maternal smoking around birth 1.08 1 0 0.0 0.00 1.00000 CCDC88B
Fed-up feelings 1.96 2 1 2.2 0.00 1.00000 CCDC88B SH2B3
Taking other prescription medications 3.72 2 1 2.2 0.00 1.00000 GSDMB SH2B3
Age when periods started (menarche) 0.81 1 0 0.0 0.00 1.00000 SLC9B1
Heel bone mineral density (BMD) T-score, automated (left) 1.77 1 0 0.0 0.00 1.00000 DDX6
High blood pressure 3.15 3 1 2.2 1.00 0.00349 KPNA4 SH2B3 TRIM59
Hayfever, allergic rhinitis or eczema 7.46 5 4 8.9 0.23 0.70730 DDX6 DEXI GSDMB IL7R SLC9B1
Medication: Atenolol 2.16 1 1 2.2 0.00 1.00000 SH2B3
Medication: Levothyroxine sodium 6.43 3 1 2.2 0.00 1.00000 CCDC88B IL7R SH2B3
Sitting height 0.55 2 0 0.0 0.00 1.00000 CTSH RMI2
Body mass index (BMI) 0.82 1 0 0.0 0.00 1.00000 DENND1B
Impedance of leg (left) 0.81 1 0 0.0 0.00 1.00000 DENND1B
Leg predicted mass (left) 0.79 1 0 0.0 0.00 1.00000 SH2B3
Trunk fat mass 0.70 2 0 0.0 0.00 1.00000 SLC26A1 SYNGR1
Waist circumference 0.85 1 1 2.2 0.00 1.00000 SLC26A1
Past tobacco smoking 1.43 2 0 0.0 0.00 1.00000 CCDC88B SH2B3
Nervous feelings 1.25 1 0 0.0 0.00 1.00000 DENND1B
Heel bone mineral density (BMD) T-score, automated (right) 1.98 2 0 0.0 0.00 1.00000 DDX6 KPNA4
Mouth/teeth dental problems 2.19 1 0 0.0 0.00 1.00000 IRF5
Heart attack 1.55 1 0 0.0 0.00 1.00000 SH2B3
Allergy 8.26 6 5 11.1 -0.10 0.85630 ARHGAP31 DDX6 DEXI GSDMB IL7R SLC9B1
Diabetes (self-reported) 2.00 1 0 0.0 0.00 1.00000 TRIM59
Hayfever/allergic rhinitis (self-reported) 4.73 3 2 4.4 0.00 1.00000 DEXI GSDMB IL7R
Medication: Simvastatin 2.24 1 1 2.2 0.00 1.00000 CARM1
Illnesses of siblings 1.82 1 0 0.0 0.00 1.00000 SH2B3
Weight 0.89 2 0 0.0 0.00 1.00000 SH2B3 SYNGR1
Impedance of arm (right) 1.39 2 0 0.0 0.00 1.00000 SH2B3 SLC9B1
Arm fat percentage (right) 0.62 1 1 2.2 0.00 1.00000 SLC26A1
Trunk fat-free mass 1.15 5 1 2.2 -0.39 0.52023 DDX6 IL12RB2 KPNA4 SH2B3 SYNGR1
Hip circumference 0.90 2 0 0.0 0.00 1.00000 SH2B3 SYNGR1
Father's age at death 1.70 1 1 2.2 0.00 1.00000 SH2B3
Worrier / anxious feelings 1.04 1 0 0.0 0.00 1.00000 DENND1B
Number of live births 1.66 1 0 0.0 0.00 1.00000 SLC9B1
Mouth/teeth dental problems: Dentures 2.20 1 0 0.0 0.00 1.00000 GSDMB
Asthma 7.62 5 3 6.7 0.15 0.81051 CARM1 DDX6 DEXI GSDMB IL7R
Medication: Cholesterol lowering 1.38 1 0 0.0 0.00 1.00000 CARM1
Illnesses of mother 2.35 1 0 0.0 0.00 1.00000 TRIM59
Pulse wave Arterial Stiffness index 1.50 1 0 0.0 0.00 1.00000 CCDC88B
Impedance of arm (left) 1.41 2 1 2.2 0.00 1.00000 SH2B3 SLC9B1
Arm fat mass (right) 0.69 2 0 0.0 0.00 1.00000 DENND1B SLC26A1
Trunk predicted mass 1.16 5 1 2.2 -0.38 0.52544 DDX6 IL12RB2 KPNA4 SH2B3 SYNGR1
Standing height 0.46 4 1 2.2 -0.50 0.49824 CARM1 CTSH SH2B3 SYNGR1
Seen doctor (GP) for nerves, anxiety, tension or depression 1.40 1 0 0.0 0.00 1.00000 DENND1B
Birth weight of first child 2.57 1 1 2.2 0.00 1.00000 SH2B3
Blood clot in the leg (DVT) 1.19 1 0 0.0 0.00 1.00000 SH2B3
Medication for cholesterol, blood pressure or diabetes 2.56 2 1 2.2 0.00 1.00000 CARM1 SH2B3
Gout (self-reported) 3.05 3 0 0.0 0.00 1.00000 CCDC88B IRF5 SH2B3
Hypothyroidism/myxoedema (self-reported) 7.01 5 1 2.2 0.71 0.18317 CCDC88B IL7R IRF5 SH2B3 SYNGR1
Medication: Amlodipine 1.54 1 0 0.0 0.00 1.00000 SLC26A1
Medication: Ventolin 100micrograms inhaler 4.28 2 1 2.2 0.00 1.00000 DEXI GSDMB
Birth weight 1.01 1 1 2.2 0.00 1.00000 SH2B3
High blood pressure (siblings) 1.35 1 0 0.0 0.00 1.00000 SH2B3
Forced vital capacity (FVC), Best measure 0.53 1 0 0.0 0.00 1.00000 CARM1
Body fat percentage 0.81 1 1 2.2 0.00 1.00000 SLC26A1
Leg fat percentage (right) 0.92 1 1 2.2 0.00 1.00000 SLC26A1
Arm fat-free mass (right) 1.23 2 1 2.2 0.00 1.00000 SH2B3 SYNGR1
Exposure to tobacco smoke outside home 1.47 1 0 0.0 0.00 1.00000 SH2B3
Comparative body size at age 10 1.54 1 0 0.0 0.00 1.00000 TRIM59
Wheeze or whistling in the chest in last year 3.28 2 2 4.4 0.00 1.00000 DEXI GSDMB
Number of children fathered 1.73 1 0 0.0 0.00 1.00000 DENND1B
Pulse wave peak to peak time 1.41 1 0 0.0 0.00 1.00000 CCDC88B
Qualifications: College or University degree 1.55 4 0 0.0 -1.00 0.00155 CCDC88B KPNA4 SMC4 TRIM59
Medication: Blood pressure 3.09 1 1 2.2 0.00 1.00000 SH2B3
Medication: Allopurinol 3.08 2 0 0.0 0.00 1.00000 CCDC88B SH2B3
Medication: Seretide 50 evohaler 1.82 2 0 0.0 0.00 1.00000 DEXI GSDMB
Mean time to correctly identify matches 1.65 1 1 2.2 0.00 1.00000 SH2B3
Whole body fat mass 0.74 1 0 0.0 0.00 1.00000 SLC26A1
Leg fat mass (right) 0.79 1 0 0.0 0.00 1.00000 SLC26A1
Arm predicted mass (right) 1.25 2 1 2.2 0.00 1.00000 SH2B3 SYNGR1
Alcohol intake frequency. 1.97 2 0 0.0 0.00 1.00000 SLC9B1 TRIM59
Comparative height size at age 10 0.74 1 1 2.2 0.00 1.00000 SH2B3
Suffer from 'nerves' 2.55 2 0 0.0 0.00 1.00000 SMC4 TRIM59
Overall health rating 1.61 1 0 0.0 0.00 1.00000 TRIM59
Chest pain or discomfort 1.13 1 0 0.0 0.00 1.00000 GSDMB
Medication: Aspirin 1.45 1 0 0.0 0.00 1.00000 SH2B3
Knee pain experienced in last month 1.68 1 0 0.0 0.00 1.00000 DEXI
Hypertension (Self-reported) 2.92 2 1 2.2 0.00 1.00000 SH2B3 TRIM59
Illnesses of father: Heart disease 1.36 1 0 0.0 0.00 1.00000 SH2B3
Smoking status: Previous 1.56 1 0 0.0 0.00 1.00000 SH2B3
Whole body fat-free mass 1.07 2 1 2.2 0.00 1.00000 SH2B3 SYNGR1
Leg fat-free mass (right) 0.87 1 0 0.0 0.00 1.00000 SH2B3
Arm fat percentage (left) 0.65 1 1 2.2 0.00 1.00000 SLC26A1
Average weekly red wine intake 1.31 1 0 0.0 0.00 1.00000 GSDMB
Loneliness, isolation 1.26 1 0 0.0 0.00 1.00000 SH2B3
Diabetes diagnosed by doctor 2.17 1 0 0.0 0.00 1.00000 TRIM59
Mouth/teeth dental problems: Mouth ulcers 11.34 10 6 13.3 -0.55 0.05026 DENND1B IL12A IL12RB2 IL7R IRF5 KPNA4 SH2B3 SLC9B1 SMC4 TRIM59
Medication for cholesterol 2.68 1 1 2.2 0.00 1.00000 SH2B3
Asthma (self-reported) 7.68 5 3 6.7 0.18 0.76933 CARM1 DDX6 DEXI GSDMB IL7R
Osteoporosis (self-reported) 1.30 1 0 0.0 0.00 1.00000 CCDC88B
Illnesses of father: None of the above (group 1) 1.81 1 0 0.0 0.00 1.00000 SH2B3
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.45 1 1 2.2 0.00 1.00000 GSDMB
Whole body water mass 1.08 4 1 2.2 -0.22 0.78182 DDX6 KPNA4 SH2B3 SYNGR1
Leg predicted mass (right) 0.86 1 0 0.0 0.00 1.00000 SH2B3
Arm fat mass (left) 0.71 2 0 0.0 0.00 1.00000 DENND1B SLC26A1
Number of self-reported non-cancer illnesses 4.17 4 2 4.4 0.61 0.27378 GSDMB KPNA4 SH2B3 TRIM59
Miserableness 1.18 1 0 0.0 0.00 1.00000 GSDMB
Medication: Blood pressure 1.75 1 1 2.2 0.00 1.00000 SH2B3
High cholesterol (Self-reported) 3.08 1 1 2.2 0.00 1.00000 CARM1
Medication: Bendroflumethiazide 1.45 1 0 0.0 0.00 1.00000 SH2B3
Medication: Lisinopril 1.36 1 0 0.0 0.00 1.00000 SH2B3
Illnesses of father: High blood pressure 1.24 1 0 0.0 0.00 1.00000 SH2B3
Ever smoked 1.36 2 0 0.0 0.00 1.00000 CCDC88B SH2B3
Basal metabolic rate 1.02 3 1 2.2 0.00 1.00000 DDX6 SH2B3 SYNGR1
Leg fat percentage (left) 0.92 1 1 2.2 0.00 1.00000 SLC26A1
Arm fat-free mass (left) 1.31 4 1 2.2 -0.02 0.97928 DDX6 IL12RB2 SH2B3 SYNGR1
Ever had prostate specific antigen (PSA) test 1.62 1 0 0.0 0.00 1.00000 SLC26A1
Diastolic blood pressure, automated reading 3.30 2 1 2.2 0.00 1.00000 INPP1 SH2B3
Vascular/heart problems diagnosed by doctor 3.09 2 1 2.2 0.00 1.00000 SH2B3 TRIM59
Cholesterol lowering medication 3.21 2 1 2.2 0.00 1.00000 CARM1 SLC26A1
Pain experienced in last month 2.20 1 0 0.0 0.00 1.00000 SH2B3
Heart attack/myocardial infarction (self-reported) 1.66 1 0 0.0 0.00 1.00000 SH2B3
Deep venous thrombosis (DVT) (self-reported) 1.14 1 0 0.0 0.00 1.00000 SH2B3
Impedance of whole body 1.05 1 0 0.0 0.00 1.00000 SLC9B1
Leg fat mass (left) 0.82 1 0 0.0 0.00 1.00000 SLC26A1
Arm predicted mass (left) 1.28 3 1 2.2 0.00 1.00000 DDX6 SH2B3 SYNGR1

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 4 0.116 1.5
GTEx Adipose Visceral Omentum 1 0.050 1.5
GTEx Adrenal Gland 1 0.070 1.6
GTEx Artery Aorta 1 0.034 1.5
GTEx Artery Coronary 2 0.171 1.5
GTEx Artery Tibial 2 0.054 1.4
GTEx Brain Caudate basal ganglia 1 0.110 1.5
GTEx Brain Cerebellar Hemisphere 1 0.068 1.4
GTEx Brain Cerebellum 1 0.051 1.4
GTEx Brain Cortex 2 0.196 1.6
GTEx Brain Frontal Cortex BA9 1 0.110 1.6
GTEx Brain Hippocampus 0 0.000 1.5
GTEx Brain Hypothalamus 0 0.000 1.5
GTEx Brain Nucleus accumbens basal ganglia 1 0.117 1.5
GTEx Brain Putamen basal ganglia 1 0.162 1.7
GTEx Breast Mammary Tissue 1 0.051 1.4
GTEx Breast Mammary Tissue (Male) 2 0.171 1.6
GTEx Breast Mammary Tissue (Female) 1 0.062 1.4
GTEx Cells EBV-transformed lymphocytes 2 0.143 1.5
GTEx Cells Transformed fibroblasts 6 0.145 1.5
GTEx Colon Sigmoid 2 0.139 1.5
GTEx Colon Transverse 2 0.098 1.5
GTEx Esophagus Gastroesophageal Junction 0 0.000 1.5
GTEx Esophagus Mucosa 1 0.031 1.5
GTEx Esophagus Muscularis 1 0.031 1.5
GTEx Heart Atrial Appendage 2 0.128 1.5
GTEx Heart Left Ventricle 1 0.067 1.5
GTEx Liver 0 0.000 1.6
GTEx Lung 4 0.142 1.5
GTEx Muscle Skeletal 2 0.070 1.4
GTEx Nerve Tibial 1 0.024 1.5
GTEx Ovary 1 0.112 1.5
GTEx Pancreas 4 0.248 1.5
GTEx Pituitary 2 0.181 1.5
GTEx Prostate 0 0.000 1.4
GTEx Skin Not Sun Exposed Suprapubic 0 0.000 1.5
GTEx Skin Sun Exposed Lower leg 5 0.140 1.5
GTEx Small Intestine Terminal Ileum 0 0.000 1.6
GTEx Spleen 3 0.216 1.5
GTEx Stomach 1 0.069 1.5
GTEx Testis 2 0.064 1.5
GTEx Thyroid 1 0.025 1.4
GTEx Uterus 0 0.000 1.6
GTEx Vagina 0 0.000 1.5
GTEx Whole Blood 6 0.306 1.5
METSIM Adipose 3 0.066 1.4
NTR Blood 6 0.251 1.5
ROSMAP Brain Pre-frontal Cortex 3 0.069 1.3
YFS Blood 6 0.130 1.5
CommonMind Brain Pre-frontal Cortex 7 0.131 1.4
The Cancer Genome Atlas Bladder Urothelial Carcinoma 1 0.062 1.5
The Cancer Genome Atlas Breast Invasive Carcinoma 3 0.070 1.4
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 2 0.187 1.5
The Cancer Genome Atlas Colon Adenocarcinoma 2 0.100 1.5
The Cancer Genome Atlas Esophageal Carcinoma 0 0.000 1.3
The Cancer Genome Atlas Glioblastoma Multiforme 3 0.303 1.6
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 3 0.113 1.4
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 3 0.075 1.4
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 3 0.150 1.5
The Cancer Genome Atlas Brain Lower Grade Glioma 3 0.072 1.4
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 1 0.093 1.6
The Cancer Genome Atlas Lung Adenocarcinoma 2 0.070 1.5
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 4 0.164 1.5
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 1 0.064 1.4
The Cancer Genome Atlas Pancreatic Adenocarcinoma 3 0.186 1.5
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 0 0.000 1.5
The Cancer Genome Atlas Prostate Adenocarcinoma 3 0.067 1.4
The Cancer Genome Atlas Rectum Adenocarcinoma 2 0.295 1.5
The Cancer Genome Atlas Soft Tissue Sarcoma 0 0.000 1.5
The Cancer Genome Atlas Skin Cutaneous Melanoma 2 0.387 1.6
The Cancer Genome Atlas Stomach Adenocarcinoma 5 0.305 1.5
The Cancer Genome Atlas Testicular Germ Cell Tumors 3 0.241 1.5
The Cancer Genome Atlas Thyroid Carcinoma 5 0.100 1.4
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 1 0.204 1.5